share_log

Abbott Laboratories | 8-K: Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges

SEC announcement ·  Apr 17 07:39
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more